India

The facility will house sophisticated equipment, including liquid-phase peptide synthesis reactors ranging from 250 to 3,000 liters and solid-phase peptide synthesis reactors up to 500 liters.

This arrangement strengthens an existing partnership between the two pharmaceutical giants, who already collaborate on manufacturing the mpox vaccine.

She will oversee the pharmaceutical company’s operations across India, Bangladesh, Nepal, Sri Lanka, and Maldives while joining the Board of Boehringer Ingelheim India.

Novartis will continue operating its subsidiary Novartis Healthcare Private Limited, which serves as the commercial arm for the company’s operations in India.

Once fully operational, the manufacturing plant is expected to create direct employment opportunities for more than 500 people.

The World Health Organization has listed Nipah among its top ten priority diseases alongside pathogens like Covid-19 and Zika due to its potential to trigger epidemics.

The grant will enable Qure.ai to develop a comprehensive open-source multi-modal database designed to accelerate future prevention and identification innovations.

The device works by carefully opening the obstructed prostate, providing relief from lower urinary tract symptoms that significantly impact patients’ daily lives.

The collaboration aimed to support the distribution of Valneva’s single-dose vaccine, Ixchiq, in low- and middle-income countries (LMICs) across Asia.

The new facility is designed to deliver world-class injury management and rehabilitation for athletes, helping them recover faster, regain peak performance, and prepare for national and international competitions.